Articles from DocGo Inc.

DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, today announced the acquisition of PTI Health, a mid-Atlantic mobile lab collection and phlebotomy services company. This strategic move expands DocGo’s healthcare service offering to include mobile phlebotomy lab services, addressing critical gaps in diagnostic care for underserved populations. With this acquisition, DocGo will facilitate timely, convenient blood collection and additional at-home testing services for patients, offering a new level of care to those with limited access to traditional labs or transportation options.

DocGo Inc. (Nasdaq: DCGO) (“DocGo”), a leading provider of technology-enabled mobile health services, announced today that Lee Bienstock, Chief Executive Officer, will hold a fireside chat at the Needham Annual Growth Conference on Wednesday, January 15th at 12:45 – 1:25 PM Eastern Time, and will be participating in 1x1 meetings at this event. A webcast of the fireside chat will be available on the investor relations section of DocGo’s website at https://ir.docgo.com/.

DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, today announced an expanded partnership with SHL Telemedicine (NASDAQSHLT) to integrate the SmartHeart® portable 12-lead ECG device across DocGo mobile health care units. This expanded collaboration, initially launched in the New York-New Jersey area, will now bring advanced cardiovascular diagnostics to patients’ homes and underserved communities in additional markets across the country.

DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, today announced that its Ambulnz subsidiary signed a two-year renewal of its contract with a major Tennessee healthcare system. This renewal, building on a six-year partnership, highlights the Company’s reliability in delivering efficient and high-quality medical transportation services.

DocGo Inc. (Nasdaq: DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health services, today announced that its Cardiac RMS subsidiary has signed a new contract with one of the largest hospital systems in Mississippi.

DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, today announced a new contract for ambulance transport services with one of the largest health and hospital systems in North Texas.

DocGo Inc. (Nasdaq: DCGO) (“DocGo”), a leading provider of technology-enabled mobile health services, announced today that management will be participating in the following investor conferences in November:

DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, today announced financial and operating results for the quarter ended September 30, 2024.

DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, announced today that the Company will release its financial results for the third quarter ended September 30, 2024 after the markets close on Thursday, November 7, 2024. Management will also host a conference call to discuss these results at 5:00 p.m. ET on that day.

DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, today announced that its Ambulnz subsidiary has renewed its contract with Bayhealth – central and southern Delaware’s largest healthcare system – for an additional three-year term. This extension is a testament to Ambulnz’s proven success supporting Bayhealth with timely, dependable non-emergency transportation services. The Company anticipates completing more than 20,000 trips during the contract term.

DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, today announced the appointment of Stephen K. Klasko, M.D., M.B.A as the new independent, non-executive Chair of its Board of Directors, effective October 1, 2024.

DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-driven healthcare solutions, is proud to announce Eiwe Lingefors as Chief Information Officer (CIO). Lingefors most recently served as the company’s Chief Information Security Officer, and will continue in this role as well. In his new role as CIO, Lingefors will lead both DocGo’s information security and digital innovation strategy in an evolving cybersecurity landscape.

DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, announced today that it has been selected as a finalist for two separate independent awards for its compliance and risk programs. The Company was named a finalist for the 2024 NAVEX Excellence Awards in the Compliance & Risk Program of the Year category and was also named a finalist for the Best Compliance and Ethics Program (small to mid-cap) in Governance Intelligence’s Corporate Governance Awards 2024.

DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, today announced the expansion of a program to enhance healthcare access for California Medi-Cal enrollees/patients/members. The program aims to re-engage patients with the healthcare system, delivering essential care to underserved communities in Sacramento, San Diego, Riverside, Los Angeles, San Bernadino, and Orange County through a partnership with a top 10 national insurance provider.

DocGo Inc. (Nasdaq: DCGO) (“DocGo”), a leading provider of technology-enabled mobile health services, announced today that management will be participating in the following investor conferences in August and September:

DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, today announced financial and operating results for the quarter ended June 30, 2024.

DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, today announced the launch of an innovative mobile x-ray program in partnership with MinXray. The program launched in New York City to provide rapid and accessible chest x-rays for vulnerable populations and help identify active Tuberculosis (“TB”) cases.

DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, today announced that Exceptional Medical Transportation, a DocGo subsidiary with a specialty in Critical Care Transportation, has been awarded a one-year, $4 million contract extension to provide 911 basic life support services to the City of Atlantic City. The contract, which started on August 1, 2024, includes two additional one-year renewal options, potentially extending the partnership through 2027.

DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, today announced the launch of the Well Child Visits program in partnership with an insurance provider serving the New York City metropolitan area. Through DocGo’s affiliated clinical practice group, this program will increase pediatric preventative care, strengthen childhood immunization rates and promote health equity by partnering with insurance providers to identify under-engaged patients and provide them with comprehensive at-home wellness visits and/or routine vaccinations. The program is expected to expand across New York State as well as California in the coming months.

DocGo Inc. (Nasdaq: DCGO) (“DocGo”), a leading provider of technology-enabled mobile health services, announced today that Lee Bienstock, Chief Executive Officer, will participate in a fireside chat at the Canaccord Genuity 44th Annual Growth Conference on Wednesday, August 14 at 3:30 PM Eastern Time. A webcast of the event will be available on the investor relations section of DocGo’s website at https://ir.docgo.com/.

DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, announced today that the Company will release its financial results for the second quarter ended June 30, 2024 after the markets close on Wednesday, August 7, 2024. Management will also host a conference call to discuss these results at 5:00 p.m. ET on that day.

DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, today announced that its Ambulnz subsidiary has launched emergency medical and 911 services in Dover, Delaware.

DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, today announced its partnership with Spect, a leading provider of comprehensive digital services for eye exam screenings, including diabetic retinopathy. Leveraging Spect’s innovative hand-held retinal cameras, DocGo’s mobile health clinicians now have a more scalable and cost-effective way to bring diabetic retinopathy and other eye disease screening services to patients in their own homes and workplaces.

DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, today announced it has secured five new contracts that include remote patient monitoring (RPM), virtual care management (VCM), chronic care management (CCM), cardiac implantable electronic device (CIED), and a care gap closure program for a national health plan. These noteworthy examples of new DocGo contracts expand the Company’s reach and ability to deliver quality virtual, in-person, and mobile healthcare services.

DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, today announced that management is participating in the iAccess Alpha Buyside Best Ideas Summer Conference 2024 on June 25 and 26, 2024. Lee Beinstock, DocGo’s Chief Executive Officer, will deliver a company presentation at 2:00 PM Eastern Time on June 25 and host one-on-one meetings the following day, June 26.

DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, today announced the establishment of its Medical Advisory Board (MAB) to offer counsel and expertise to the Company’s executive team.

DocGo Inc. (Nasdaq: DCGO) (“DocGo”), a leading provider of technology-enabled mobile health services, today announced that Lee Bienstock, Chief Executive Officer, will present at the Stifel Cross Sector Insight Conference on Wednesday, June 5 at 1:15 PM Eastern Time. A webcast of the event will be available on the investor relations section of DocGo’s website at https://ir.docgo.com/.

DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, today announced financial and operating results for the quarter ended March 31, 2024.

DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, announced today that the Company will release its financial results for the first quarter ended March 31, 2024 after the markets close on Wednesday, May 8, 2024. Management will also host a conference call to discuss these results at 5:00 p.m. ET on that day.

DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, announced today the extension of its current migrant services contract with the New York City Department of Housing Preservation and Development (HPD). This extension is part of a planned transition that DocGo worked on in collaboration with NYC, demonstrating a continued partnership to ensure consistent and quality services for those in need.

DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, announced today that the following members of DocGo’s leadership have recently purchased shares on the open market, as follows:

DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, announced today that as of March 12, 2024, it has repurchased a total of 1.25 million shares of its common stock at an average of $3.88 per share under its share repurchase program announced on January 31, 2024 (the “Repurchase Program”). Pursuant to the Repurchase Program, DocGo is authorized to purchase up to $36 million of its common stock during a 6-month period ending July 30, 2024.

DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services in 30 states and the UK, today announced financial and operating results for the quarter and year ended December 31, 2023.

DocGo Inc. (Nasdaq: DCGO), a leading provider of technology-enabled mobile health services, today announced the addition of two senior leaders bringing significant experience in large-scale public health program management and value-based care partnerships with health plans.

DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, announced today that the Company will release its financial results for the fourth quarter and full year ended December 31, 2023 after the markets close on Wednesday, February 28, 2024. Management will also host a conference call to discuss these results at 5:00 p.m. ET on that day.

DocGo Inc. (Nasdaq: DCGO), a leading provider of technology-enabled mobile health services, announced today that management will be participating in the following investor conferences in February and March:

DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, announced today that its Board of Directors has approved a new share repurchase program pursuant to which DocGo may purchase up to $36 million of its common stock during a 6-month period ending July 30, 2024. DocGo’s prior share repurchase authorization expired on November 24, 2023. The approved amount represents approximately 10% of DocGo’s outstanding shares based on DocGo’s share price at the time of authorization, although the actual number of shares to be purchased will be based on a variety of factors including market conditions and the actual share price on the purchase dates.

As previously disclosed in our press release dated January 10, 2024, DocGo Inc. (“DocGo” or the “Company”) categorically rejects “Fuzzy Panda Research’s” (FP) January 10th assessment of DocGo’s business practices. As we previously advised our shareholders, this short seller mischaracterizes and misrepresents facts that are already known to the public, and uses unsubstantiated claims to intentionally present an overall picture of DocGo, our leadership and our business that is deliberately false, misleading and defamatory.

DocGo Inc. (“DocGo” or the “Company”) categorically rejects this purported assessment by Fuzzy Panda Research, an obscure short seller motivated solely by profit. Their so-called “research report” uses what appears to be old, public information to present an overall picture of DocGo and its business that is false, misleading and defamatory, and we intend to issue a cease-and-desist letter to the firm and are exploring all available legal means to respond. We believe this short seller is focused on personal financial gain at the expense of DocGo’s shareholders, employees, customers and other stakeholders.

DocGo Inc. (Nasdaq: DCGO) (“DocGo”), a leading provider of technology-enabled mobile health services, today announced that its medical staffing division that services federal agencies achieved the coveted ISO 9001:2015 certification. This Quality Management Systems (“QMS”) standard sets the bar for quality assurance, emphasizing continuous improvement, customer satisfaction, and efficient processes.

DocGo Inc. (Nasdaq: DCGO), a leading provider of technology-enabled mobile health services today announced their partnership to provide event medical services at Enchant Milwaukee’s Winter Village.

DocGo Inc. (Nasdaq:DCGO), a leading provider of technology-enabled mobile health services, today announced the expansion of its vaccination and public health initiatives in Arizona through a new contract with the Department of Health in Santa Cruz County, Arizona.

DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, today announced financial and operating results for the quarter ended September 30, 2023.

DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, today announced that the Company will release its financial results for the third quarter ended September 30, 2023 after the markets close on Monday, November 6, 2023. Management will also host a conference call to discuss these results at 5:00 p.m. EDT on that day.

DocGo Inc. (Nasdaq: DCGO), a leading provider of technology-enabled mobile health services, announced today that its staffing division Rapid Temps by DocGo has earned The Joint Commission’s Gold Seal of Approval® for Health Care Staffing Services Certification by demonstrating continuous compliance with Joint Commission performance standards. The Gold Seal is a symbol of quality that reflects Rapid Temps by DocGo’s commitment to providing safe and quality patient care.

DocGo Inc. (Nasdaq:DCGO), a leading provider of technology-enabled mobile health services, is proud to be Certified™ by Great Place To Work®. The prestigious award is based entirely on what current employees say about their experience working at DocGo. This is the company’s second time participating in the certification process, and the second time it earned the prized certification.

DocGo Inc. (Nasdaq:DCGO), a leading provider of technology-enabled mobile health services, announced today that its UK-based subsidiary, Ambulnz Community Partners, has been awarded a 5-year contract to provide emergency and urgent ambulance services for South Central Ambulance Service NHS Foundation Trust.

DocGo Inc. (Nasdaq:DCGO), a leading provider of last-mile mobile health services, announced today that its UK-based subsidiary, Ambulnz Community Partners, is adding six electric ambulances to their fleet. Through a partnership with Stockport NHS Foundation Trust, the first of these electric ambulances went into operational service this month. Non-emergency patients can now be transported to and from Stepping Hill Hospital in the environmentally friendly vehicle. Plans to operationalize the full fleet of electric ambulances are underway.

DocGo Inc. (Nasdaq: DCGO), a leading provider of last-mile mobile health services today announced financial and operating results for the quarter ended June 30, 2023.

DocGo Inc. (Nasdaq: DCGO), a leading provider of last-mile mobile health services today announced financial and operating results for the quarter ended March 31, 2023.

DocGo Inc. (Nasdaq: DCGO), a leading provider of last-mile mobile health services, today announced financial and operating results for the fourth quarter and full-year ended December 31, 2022.

DocGo Inc. (Nasdaq: DCGO), a leading provider of last-mile mobile health services, today announced a partnership with Redirect Health, a platform that creates and manages healthcare solutions for businesses and employees nationwide, to provide on-demand, urgent mobile care to patients in New Jersey and New York. Through Redirect Health’s referral team, DocGo On-Demand mobile services are called into action, preventing potential emergency room visits and ultimately lowering costs while facilitating high-quality patient care. The partnership will enable DocGo to provide its rapid, in-home mobile health services to thousands of Redirect Health’s members across New Jersey and New York.

DocGo Inc. (Nasdaq: DCGO), a leading provider of last-mile mobile health services, announced today that its co-founder and current Chairman of the Board and Chief Executive Officer Stan Vashovsky will continue to serve as non-executive Chairman of its Board of Directors beginning on January 1, 2023 and following his retirement as Chief Executive Officer of the Company. The company had previously announced that Mr. Vashovsky will retire as Chief Executive Officer of the Company as of December 31, 2022 and step down from the Board of Directors and his Chairman position at the same time. The company believes it is in its best interests to have Mr. Vashovsky continue to serve as Chairman given DocGo’s strong growth outlook. Ira Smedra, who was to succeed Mr. Vashovsky as Chairman on January 1, 2023, will continue serving as a member of DocGo’s Board of Directors. As previously disclosed, current President Anthony Capone will succeed Mr. Vashovsky as Chief Executive Officer beginning on January 1, 2023.

DocGo Inc. (Nasdaq: DCGO), a leading provider of last-mile mobile health services, today announced financial and operating results for the third quarter ending September 30, 2022.

DocGo, a leading provider of last-mile mobile health services (Nasdaq: DCGO), announced today that its UK-based subsidiary, Ambulnz Community Partners, has been awarded three new contracts. Reflecting the continued growth of Ambulnz Community Partners in the UK, and particularly in the North West of England, these contracts will continue to drive growth in Greater Manchester, and also provide expanded services in Lancashire and Merseyside.

DocGo (Nasdaq: DCGO), a leading provider of last-mile mobile health services, announced today that Anthony Capone, President will participate at the H.C. Wainwright 24th Annual Global Investment Conference on Tuesday, September 13 at 1:30PM Eastern Time. A webcast of the event will be available on the investor relations section of DocGo’s website at https://ir.docgo.com/.

DocGo, a leading provider of last-mile mobile health services (Nasdaq: DCGO), announced today a new contract to provide mobile health services to Horizon Healthcare Services, Inc. (Horizon) members, covering commercial and Medicare populations in New Jersey. The arrangement includes Braven Health, a joint venture between Horizon and New Jersey’s largest health systems (Hackensack Meridian Health and RWJ Barnabas Health) that offers Medicare Advantage plans in New Jersey. The network agreement with Horizon allows DocGo to potentially reach an additional 3.8 million people with its range of mobile health services.

DocGo Inc., a leading provider of last-mile mobile health services (Nasdaq: DCGO), announced today that it will redeem all of its outstanding warrants (the “Public Warrants”) to purchase shares of DocGo’s common stock, par value $0.0001 per share (the “Common Stock”), that were issued under the Warrant Agreement, dated as of October 14, 2020 (the “Warrant Agreement”), by and between Motion Acquisition Corp. (“Motion”) and Continental Stock Transfer & Trust Company, as warrant agent (the “Warrant Agent”), as part of the units sold in Motion’s initial public offering (the “IPO”), and that remain outstanding at 5:00 p.m. New York City time on September 16, 2022 (the Redemption Date”) for a redemption price of $0.10 per Public Warrant. In addition, DocGo will redeem all of its outstanding warrants to purchase Common Stock that were issued under the Warrant Agreement in a private placement simultaneously with the IPO (the “Private Warrants” and, together with the Public Warrants, the “Warrants”).

DocGo Inc. (Nasdaq: DCGO), a leading provider of last-mile mobile health services, today announced financial and operating results for the second quarter ending June 30, 2022.

DocGo Inc., a leading provider of last-mile mobile health services and integrated medical mobility solutions (Nasdaq:DCGO), announced the award of two new contracts to Ambulnz by DocGo in the state of Nevada. The mobile health contracts include COVID-19 testing, COVID-19 vaccine programs, and at-home monoclonal antibody infusion treatments to eligible patients across the state of Nevada. These contracts were awarded to several companies; the combined value of DocGo’s award is estimated at $55 million over the next three years.